Phase 2
Completed N=15
Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)
Source: ClinicalTrials.gov NCT01100255 ↗Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Oct 2016
Primary outcomePrimary: Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale. — 0; 5 participants
Summary
In this study investigators are studying the effects of a drug called ketamine on the symptoms of Obsessive-compulsive disorder (OCD).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Patients Who Met and Exceeded Response Criteria of Yale-Brown Obsessive-Compulsive Scale. |
0; 5 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18-55
- Physically healthy and not currently pregnant
- Primary Diagnosis of OCD
- Sufficient severity of symptoms
- Able to provide consent
Exclusion Criteria
- Psychiatric conditions that make participation unsafe
- Currently on psychotropic medication
- Medical conditions that make participation unsafe
- Allergy to ketamine
- Any metal in the body
Data sourced from ClinicalTrials.gov (NCT01100255). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.